查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1308654

2030 年面部注射劑市場預測 - 按產品類型、應用、最終用戶和地區劃分的全球分析

Facial Injectables Market Forecasts to 2030 - Global Analysis By Product Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球面部注射市場規模將達到 59.4 億美元，預計在預測期內復合年增長率為 11.6%，到 2030 年將達到 128 億美元。

真皮填充劑，也稱為面部注射，是一種使面部恢復活力的化妝品。為了改善美觀，這些面部注射產品通常用於治療皺紋和其他早期衰老跡象。它還有助於人口老齡化和更好的面部注射劑（例如人造氫氧化鈣填充劑）的開發。

據美國整形外科醫生協會 (ASPS) 統計，2019 年美國約 25.0% 的整容手術是在醫院進行的。

市場動態：

促進者

對微創美容手術的需求不斷增長

全球面部注射市場預計將在預測期內推動增長，由於對最短恢復時間、減輕疼痛和降低手術相關風險的渴望，將推動對非侵入性整容手術的需求迅速增長。對於那些想在不進行手術的情況下改善外表的人來說，面部注射是一種方便、非侵入性的選擇。社交媒體和因人們渴望向世界展示自己最好的一面而發展起來的自拍文化也推動了這一趨勢。

抑製劑

非常貴

預計全球面部注射劑市場在預測期內的增長將受到阻礙。面部注射的高昂費用可能成為患者接受治療的重大障礙，特別是在發展中國家，那裡的治療對許多人來說往往很昂貴。此外，這些治療方法的高價格可能會阻礙患者接受維持注射，從而導致公司的整體市場回報較低。為了解決這個問題，一些運營商正在尋找替代定價結構，例如統一費率計劃。

機會：

對聯合療法的興趣日益濃厚

預計全球面部注射劑市場將在預測期內推動增長。混合各種面部注射（包括填充劑和神經調節劑）的組合療法越來越受歡迎。能夠提供包含多種療法的綜合治療方案的公司可能會從這一趨勢中受益。例如，一些公司現在提供“液體整容”治療，將注射與其他微創技術相結合，提供完整的面部年輕化解決方案。

威脅：

供應鏈中斷

預計全球面部注射市場在預測期內將阻礙增長。例如，原材料和製造設備的短缺可能會導致面部注射市場的混亂。這些障礙可能導致產品開發和製造延遲、供應減少和消費價格上漲。為了應對這一威脅，市場上的公司必須實現供應鏈多元化，投資於庫存管理系統，並與供應商保持牢固的聯繫，以確保原材料的穩定供應。

COVID-19 的影響：

由於安全問題、金融不穩定、供應鏈中斷和監管審查加強，COVID-19 大流行影響了面部注射劑市場，導致需求減少。為了適應這種情況，公司正在投資新技術、安全程序和產品開發。隨著企業應對疫情的挑戰，市場可能會保持活力和創新。隨著世界努力應對這一流行病的挑戰，面部注射市場可能會保持活力和創新。

在預測期內，真皮填充劑預計將成為最大的細分市場：

真皮填充劑預計將在預測期內佔據最大份額。與外科手術相比，真皮填充劑因其效率高、價格實惠且並發症風險相對較低而廣受歡迎。它們用於恢復體積和撫平皺紋。這種市場滲透是由具有不同配方和注射方法的各種真皮填充劑產品的可用性推動的。人口老齡化、對非手術整容手術的認識和接受度不斷提高以及持續的產品創新都將促進這一增長。隨著真皮填充劑需求的增加，面向市場的公司可能會投資研發來開發新的和改進的產品，這些產品可以提供更好的效果、更持久的效果和更少的副作用。

預計門診手術中心部分在預測期內將呈現最高的複合年增長率：

預計門診手術中心部分在預測期內將呈現最快的複合年增長率。您可以選擇手術和非手術程序。影響該市場增長的因素包括對微創整容手術的需求不斷增長、人們對面部注射益處的了解不斷增加以及 ASC 的接受度不斷提高。許多 ASC 還投資新技術、設備和員工培訓，為患者提供安全有效的美容服務。

佔比最大的地區

由於對非侵入性整容手術的高需求，預計北美區域市場在預測期內將佔全球面部注射劑市場的最大份額，其中美國是北美最大的面部注射劑市場..由於人們對整容手術的認識和接受程度提高，以及各種面部注射產品的出現，該地區的市場不斷增長。由於微創美容手術的接受度不斷提高以及技術的持續發展，北美面部注射市場預計將在未來幾年擴大。

複合年增長率最高的地區：

預計亞太地區在預測期內的複合年增長率最高。對非手術整容手術的需求不斷增長、可支配收入增加以及人們對整容手術的認識和接受度不斷提高，促進了該地區的增長。尖端、新穎的面部注射產品的出現以及提供這些服務的醫療機構和醫療專業人員數量的不斷增加預計將支持該地區的增長。此外，由於泰國、韓國和印度等國家醫療旅遊的增長趨勢，亞太面部注射器市場預計將增長。

主要發展：

2022 年 8 月，Allergan Healthcare India在其Allergan Aesthetics美容業務部門推出了 Juvederm VOLUX，這是一種可注射植入物，旨在恢復和塑造面部體積。

2022 年 3 月，Galderma 在 AMWC 2022 上展示了其真皮填充劑、膠原蛋白生物刺激劑和液體神經調節劑產品組合的新臨床數據和高患者滿意度。在 2022 年美容與抗衰老醫學世界大會上，Galderma 展示了有關其透明質酸真皮填充劑系列產品組合、首款液體神經調節劑和原創膠原蛋白生物刺激劑的一系列新科學數據。

2022 年 2 月，Amnir 推出四種新產品，擴大了其註射劑產品組合。地塞米松磷酸鈉注射液USP 10mg/mL、氮胞甘100mg、卡前列米胺注射液USP 250mcg/mL、硫酸阿托品注射液USP 0.5mg/5mL 已收到美國食品和藥物管理局的簡短新藥申請。地塞米松和阿扎胞甘目前均在 FDA 的短缺藥物名單上，阿托品已獲得 FDA 的競爭性仿製藥治療批准。

報告內容

  • 區域和國家層面的市場份額評估
  • 對新進入者的戰略建議
  • 涵蓋 2021、2022、2023、2026 和 2030 年的市場數據
  • 市場趨勢（市場驅動因素/制約因素/機會/威脅/挑戰/投資機會/建議）
  • 根據市場預測提出關鍵業務領域的戰略建議
  • 競爭格局繪製主要流行趨勢
  • 公司概況，包括詳細戰略、財務狀況和近期發展
  • 映射最新技術進步的供應鏈趨勢

免費定制服務：

訂閱此報告的客戶將獲得以下免費定制選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要公司的SWOT分析（最多3家公司）
  • 地理細分
    • 根據客戶興趣對主要國家的市場估計/預測/複合年增長率（注：通過可行性檢查）
  • 競爭標桿
    • 根據產品組合、地域分佈和戰略聯盟對主要參與者進行基準測試

目錄

第一章內容提要

第二章前言

  • 概述
  • 利益相關者
  • 調查範圍
  • 調查方法
    • 數據挖掘
    • 數據分析
    • 數據驗證
    • 研究方法
  • 研究來源

第三章市場趨勢分析

  • 促進者
  • 抑製劑
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5.全球面部注射劑市場，按產品類型

  • 皺紋鬆弛劑
    • A型肉毒桿菌毒素
  • 真皮填充劑
    • 膠原
    • 透明質酸
    • 羥基磷灰石鈣
    • 聚乳酸
    • 聚甲基丙烯酸甲酯微球（PMMA）
    • 脂肪注射
  • 聚合物填料
  • 其他產品類型

6.全球面部注射劑市場（按應用）

  • 減少皺紋
  • 面部提升術
  • 美學
  • 療法
  • 痤瘡疤痕治療
  • 脂肪營養不良的治療
  • 面部線條矯正
  • 豐唇術
  • 其他用途

7. 全球面部注射劑市場（按最終用戶）

  • 醫院
  • 門診手術中心
  • 皮膚科診所
  • 化妝品中心
  • 皮膚病學調查
  • 美容診所
  • 醫療水療
  • 其他最終用戶

8.全球面部注射劑市場（按地區）

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 意大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 新西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中東和非洲
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 卡塔爾
    • 南非
    • 其他中東和非洲

第九章 主要進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第十章公司簡介

  • Allergan, Plc.
  • Alma Laser
  • Anika Therapeutics, Inc.
  • Antares Pharma
  • Bausch Health Companies In
  • BIOPLUS CO., LTD.
  • Bioxis Pharmaceuticals
  • Bloomage BioTechnology Corporation Limited
  • ColBar LifeScience Ltd.
  • Dickinson and Company
  • Galderma Pharma S.A.
  • Ipsen Pharma
  • Medytox, Inc.
  • Merz Pharma
  • Prollenium Medical Technologies Inc.
  • Revance Therapeutics, Inc.
  • Sinclair Pharma Plc
  • Solta Medical
  • Suneva Medical, Inc.
  • Syneron Candela
Product Code: SMRC23354

According to Stratistics MRC, the Global Facial Injectables Market is accounted for $5.94 billion in 2023 and is expected to reach $12.80 billion by 2030 growing at a CAGR of 11.6% during the forecast period. Dermal fillers, also referred to as facial injectable products, are cosmetics that rejuvenate the face. In order to improve aesthetic beauty, these facial injectable products are typically used to treat wrinkles and other early signs of aging. It is also aided in the number of elderly people and the development of superior facial injectables like artificial calcium hydroxylapatite fillers.

According to the American Society of Plastic Surgeons (ASPS), in 2019, an estimated 25.0% of cosmetic procedures were performed in hospitals in the United States.

Market Dynamics:

Driver:

Increasing demand for minimally invasive cosmetic procedures

The global Facial Injectables market expected to drive growth during the forecast period, due to the desire for minimal recovery time, less pain, and fewer risks associated with surgery, the demand for non-invasive cosmetic procedures is increasing quickly. People who want to enhance their appearance without having surgery have a convenient, non-invasive option with facial injectables. Social media and the selfie culture that has developed as a result of people's increasing desire to present their best selves to the world have also contributed to this trend.

Restraint:

Very expensive

The global Facial Injectables market expected to hinder growth during the forecast period. Particularly in developing nations, where the cost of treatment can be prohibitive for many people, the high cost of facial injectables can be a major barrier to patient uptake. Additionally, the high price of these treatments may deter patients from getting maintenance injections, resulting in lower overall market revenue for businesses. In an effort to resolve this problem, some businesses are looking into different pricing structures, like subscription-based plans, which might make facial injectables more affordable for a wider range of patients.

Opportunity:

Rising interest in combination therapies

The global Facial Injectables market expected to drive growth during the forecast period. Combination therapies, which mix various facial injectables, including fillers and neuromodulators, are gaining popularity. Businesses that can provide comprehensive treatment options that incorporate multiple therapies will probably be well-positioned to benefit from this trend. As an illustration, some businesses now provide "liquid facelift" treatments that combine injectables with other minimally invasive techniques to offer a complete facial rejuvenation solution.

Threat:

Disruptions in the supply chain

The global Facial Injectables market expected to hamper growth during the forecast period. A disruption in the facial injectables market could result from a lack of raw materials or manufacturing equipment, for example. These setbacks may result in slower product development and manufacturing, a smaller supply, and higher consumer prices. Companies in the market need to diversify their supply chains, make investments in inventory management systems, and keep strong ties with suppliers to guarantee a steady supply of raw materials to combat this threat.

COVID-19 Impact:

Due to safety concerns, financial uncertainty, disruption of supply chains, and increased regulatory scrutiny, the COVID-19 pandemic has had an impact on the facial injectables market, resulting in decreased demand. To adapt, businesses have made investments in new technologies, safety procedures, and product development. As businesses navigate the challenges of the pandemic, the market is likely to remain dynamic and innovative. The facial injectables market is likely to stay dynamic and innovative as the world struggles to deal with the pandemic's challenges because businesses are working hard to meet patients' changing needs in an environment that is changing quickly.

The dermal fillers segment is expected to be the largest during the forecast period:

The dermal fillers segment is expected to be the largest share during the forecast period Dermal fillers are popular for their efficiency, affordability, and comparably low risk of complications when compared to surgical procedures. They are used to restore volume and smooth out wrinkles. The proliferation of this market has been aided by the accessibility of a wide variety of dermal filler products with various formulations and injection methods. The aging population, rising awareness and acceptance of non-surgical cosmetic procedures, and ongoing product innovation will all contribute to this growth. Companies in the market are likely to invest in R&D to develop new and improved products that offer better results, longer-lasting effects, and fewer side effects as the demand for dermal fillers rises.

The ambulatory surgery centers segment is expected to have the highest CAGR during the forecast period:

The ambulatory surgery centers segment is anticipated to witness the fastest CAGR growth during the forecast period Patients looking to enhance their appearance can choose from a variety of surgical and non-surgical procedures at ambulatory surgery centers (ASCs), including facial injectables. Some of the factors influencing the growth of this market include the rising demand for minimally invasive cosmetic procedures, the growing knowledge of the advantages of facial injectables, and the increasing acceptance of ASCs. In order to offer their patients safe and effective cosmetic services, many ASCs have also made investments in new technologies, equipment, and staff training.

Region with largest share:

The North America region market is estimated to witness a largest share of the global Facial Injectables market during the forecast period, due to the high demand for non-invasive aesthetic procedures, the United States is North America's largest market for facial injectables. The market in this region has expanded as a result of rising awareness and acceptance of cosmetic procedures as well as the availability of a wide variety of facial injectable products. The market for facial injectables in North America is anticipated to expand over the ensuing years, helped along by the rising acceptance of minimally invasive cosmetic procedures and ongoing developments in technology.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period. The demand for non-surgical cosmetic procedures is rising, there is more disposable income available, and people are becoming more aware of and accepting of aesthetic procedures, all of which contribute to this region's growth. The availability of cutting-edge and novel facial injectable products, as well as the rising number of healthcare facilities and medical professionals providing these services, are anticipated to support growth in this area. Additionally, the market for facial injectables in Asia Pacific is anticipated to expand as a result of the expanding trend of medical tourism in nations like Thailand, South Korea, and India.

Key players in the market

Some of the key players in Facial Injectables market include Allergan, Plc., Alma Laser , Anika Therapeutics, Inc., Antares Pharma , Bausch Health Companies In, BIOPLUS CO., LTD., Bioxis Pharmaceuticals, Bloomage BioTechnology Corporation Limited , ColBar LifeScience Ltd., Dickinson and Company, Galderma Pharma S.A., Ipsen Pharma, Medytox, Inc., Merz Pharma, Prollenium Medical Technologies Inc., Revance Therapeutics, Inc., Sinclair Pharma Plc, Solta Medical, Suneva Medical, Inc. and Syneron Candela.

Key Developments:

In August 2022, Allergan Healthcare India launched Juvederm VOLUX, an injectable implant intended to restore and create the volume of the face, under its Business Unit of Allergan Aesthetics.

In March 2022, Galderma presented its new clinical data and high patient satisfaction across its portfolio of dermal fillers, collagen bio stimulators, and liquid neuromodulators at AMWC 2022. Galderma presented a range of new scientific data on its portfolio on its hyaluronic acid dermal filler range, its first liquid neuromodulator, and its original collagen biostimulator at the Aesthetic & Anti-Aging Medicine World Congress 2022.

In February 2022, Amneal expanded its injectables portfolio with 4 new products. Dexamethasone sodium phosphate injection, USP 10 mg/mL, azacitidine 100 mg, carboprost tromethamine injection, USP 250 mcg/mL, and atropine sulfate injection, USP 0.5 mg/5 mL, have received Abbreviated New Drug Application approval from the US Food and Drug Administration. Dexamethasone and azacitidine are both currently on the FDA drug shortage list, and Atroprine was granted Competitive Generic Therapy status by the FDA.

Product Types Covered:

  • Wrinkle Relaxers
  • Dermal Fillers
  • Polymer Fillers
  • Other Product Types

Applications Covered:

  • Wrinkle Reduction
  • Facelift
  • Aesthetics
  • Therapeutics
  • Acne Scar Treatment
  • Lipoatrophy Treatment
  • Facial Line Correction
  • Lip Augmentation
  • Other Applications

End Users Covered:

  • Hospitals
  • Ambulatory Surgery Centers
  • Dermatology Clinics
  • Cosmetic Centers
  • Dermatology Research Institutes
  • Beauty Clinics
  • Medical Spas
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Facial Injectables Market, By Product Type

  • 5.1 Introduction
  • 5.2 Wrinkle Relaxers
    • 5.2.1 Botulinum Toxin Type A
  • 5.3 Dermal Fillers
    • 5.3.1 Collagen
    • 5.3.2 Hyaluronic Acid
    • 5.3.3 Calcium Hydroxylapatite
    • 5.3.4 Polylactic Acid
    • 5.3.5 Polymethyl-methacrylate Microspheres (PMMA)
    • 5.3.6 Fat Injection
  • 5.4 Polymer Fillers
  • 5.5 Other Product Types

6 Global Facial Injectables Market, By Application

  • 6.1 Introduction
  • 6.2 Wrinkle Reduction
  • 6.3 Facelift
  • 6.4 Aesthetics
  • 6.5 Therapeutics
  • 6.6 Acne Scar Treatment
  • 6.7 Lipoatrophy Treatment
  • 6.8 Facial Line Correction
  • 6.9 Lip Augmentation
  • 6.10 Other Applications

7 Global Facial Injectables Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Ambulatory Surgery Centers
  • 7.4 Dermatology Clinics
  • 7.5 Cosmetic Centers
  • 7.6 Dermatology Research Institutes
  • 7.7 Beauty Clinics
  • 7.8 Medical Spas
  • 7.9 Other End Users

8 Global Facial Injectables Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Allergan, Plc.
  • 10.2 Alma Laser
  • 10.3 Anika Therapeutics, Inc.
  • 10.4 Antares Pharma
  • 10.5 Bausch Health Companies In
  • 10.6 BIOPLUS CO., LTD.
  • 10.7 Bioxis Pharmaceuticals
  • 10.8 Bloomage BioTechnology Corporation Limited
  • 10.9 ColBar LifeScience Ltd.
  • 10.10 Dickinson and Company
  • 10.11 Galderma Pharma S.A.
  • 10.12 Ipsen Pharma
  • 10.13 Medytox, Inc.
  • 10.14 Merz Pharma
  • 10.15 Prollenium Medical Technologies Inc.
  • 10.16 Revance Therapeutics, Inc.
  • 10.17 Sinclair Pharma Plc
  • 10.18 Solta Medical
  • 10.19 Suneva Medical, Inc.
  • 10.20 Syneron Candela

List of Tables

  • Table 1 Global Facial Injectables Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Facial Injectables Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Facial Injectables Market Outlook, By Wrinkle Relaxers (2021-2030) ($MN)
  • Table 4 Global Facial Injectables Market Outlook, By Botulinum Toxin Type A (2021-2030) ($MN)
  • Table 5 Global Facial Injectables Market Outlook, By Dermal Fillers (2021-2030) ($MN)
  • Table 6 Global Facial Injectables Market Outlook, By Collagen (2021-2030) ($MN)
  • Table 7 Global Facial Injectables Market Outlook, By Hyaluronic Acid (2021-2030) ($MN)
  • Table 8 Global Facial Injectables Market Outlook, By Calcium Hydroxylapatite (2021-2030) ($MN)
  • Table 9 Global Facial Injectables Market Outlook, By Polylactic Acid (2021-2030) ($MN)
  • Table 10 Global Facial Injectables Market Outlook, By Polymethyl-methacrylate Microspheres (PMMA) (2021-2030) ($MN)
  • Table 11 Global Facial Injectables Market Outlook, By Fat Injection (2021-2030) ($MN)
  • Table 12 Global Facial Injectables Market Outlook, By Polymer Fillers (2021-2030) ($MN)
  • Table 13 Global Facial Injectables Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 14 Global Facial Injectables Market Outlook, By Application (2021-2030) ($MN)
  • Table 15 Global Facial Injectables Market Outlook, By Wrinkle Reduction (2021-2030) ($MN)
  • Table 16 Global Facial Injectables Market Outlook, By Facelift (2021-2030) ($MN)
  • Table 17 Global Facial Injectables Market Outlook, By Aesthetics (2021-2030) ($MN)
  • Table 18 Global Facial Injectables Market Outlook, By Therapeutics (2021-2030) ($MN)
  • Table 19 Global Facial Injectables Market Outlook, By Acne Scar Treatment (2021-2030) ($MN)
  • Table 20 Global Facial Injectables Market Outlook, By Lipoatrophy Treatment (2021-2030) ($MN)
  • Table 21 Global Facial Injectables Market Outlook, By Facial Line Correction (2021-2030) ($MN)
  • Table 22 Global Facial Injectables Market Outlook, By Lip Augmentation (2021-2030) ($MN)
  • Table 23 Global Facial Injectables Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 24 Global Facial Injectables Market Outlook, By End User (2021-2030) ($MN)
  • Table 25 Global Facial Injectables Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 26 Global Facial Injectables Market Outlook, By Ambulatory Surgery Centers (2021-2030) ($MN)
  • Table 27 Global Facial Injectables Market Outlook, By Dermatology Clinics (2021-2030) ($MN)
  • Table 28 Global Facial Injectables Market Outlook, By Cosmetic Centers (2021-2030) ($MN)
  • Table 29 Global Facial Injectables Market Outlook, By Dermatology Research Institutes (2021-2030) ($MN)
  • Table 30 Global Facial Injectables Market Outlook, By Beauty Clinics (2021-2030) ($MN)
  • Table 31 Global Facial Injectables Market Outlook, By Medical Spas (2021-2030) ($MN)
  • Table 32 Global Facial Injectables Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.